Prestige Consumer Healthcare Inc. Financial Summary

Quick Answer

Prestige Consumer Healthcare Inc. reported Total Revenue of $1.14 billion for fiscal year 2025.

Prestige Consumer Healthcare Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $1.14B
+1.1%
$1.13B
-0.2%
$1.13B
+3.8%
$1.09B
+15.2%
$943.37M
-2.0%
$963.01M
-1.3%
Revenue (ASC 606) $1.14B
+1.1%
$1.13B
-0.2%
$1.13B
+3.8%
$1.09B
+15.2%
$943.37M
-2.0%
$963.01M
-1.3%
Net Income $214.60M
+2.5%
$209.34M
+354.3%
-$82.31M
-140.1%
$205.38M
+24.7%
$164.68M
+15.7%
$142.28M
+497.4%
Diluted EPS $4.29
+2.9%
$4.17
+352.7%
-$1.65
-140.8%
$4.04
+24.3%
$3.25
+16.9%
$2.78
+502.9%
Total Assets $3.40B
+2.5%
$3.32B
-1.1%
$3.35B
-8.6%
$3.67B
+7.0%
$3.43B
-2.4%
$3.51B
+2.1%
Cash and Equivalents $97.88M
+110.6%
$46.47M
-20.6%
$58.49M
+115.2%
$27.18M
-15.8%
$32.30M
-65.9%
$94.76M
+244.2%
Long-Term Debt $992.36M
-11.9%
$1.13B
-16.3%
$1.35B
-8.9%
$1.48B
-0.2%
$1.48B
-14.5%
$1.73B
-3.8%
Stockholders Equity $1.83B
+10.9%
$1.66B
+14.4%
$1.45B
-8.3%
$1.58B
+16.1%
$1.36B
+16.0%
$1.17B
+6.9%
Operating Income $336.77M
-1.7%
$342.43M
+1627.7%
-$22.41M
-106.8%
$329.92M
+10.9%
$297.40M
+2.1%
$291.15M
+331.3%
Gross Profit $634.46M
+1.6%
$624.45M
-0.1%
$625.29M
+0.7%
$620.65M
+13.4%
$547.47M
-0.9%
$552.22M
-0.6%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $283.44M -2.4% +3.4%
Revenue (ASC 606) December 31, 2025 $283.44M -2.4% +3.4%
Net Income December 31, 2025 $46.70M -23.5% +10.6%
Diluted EPS December 31, 2025 $0.97 -20.5% +12.8%
Total Assets December 31, 2025 $3.49B +5.0% +1.5%
Cash and Equivalents December 31, 2025 $62.37M +22.6% -47.6%
Long-Term Debt December 31, 2025 $1.03B +4.2% +4.1%
Stockholders Equity December 31, 2025 $1.83B +2.3% +0.2%
Operating Income December 31, 2025 $82.49M -10.3% +3.5%
Gross Profit December 31, 2025 $157.37M -2.3% +3.8%
  • Prestige Consumer Healthcare Inc. reported Total Revenue of $1.14 billion for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +1.1% in Total Revenue compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Revenue (ASC 606) of $1.14 billion for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +1.1% in Revenue (ASC 606) compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Net Income of $214.60 million for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +2.5% in Net Income compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Diluted EPS of $4.29 per share for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +2.9% in Diluted EPS compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Total Assets of $3.40 billion for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +2.5% in Total Assets compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Cash and Equivalents of $97.88 million for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +110.6% in Cash and Equivalents compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Long-Term Debt of $992.36 million for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed a decrease of -11.9% in Long-Term Debt compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Stockholders Equity of $1.83 billion for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +10.9% in Stockholders Equity compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Operating Income of $336.77 million for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed a decrease of -1.7% in Operating Income compared to the prior fiscal year.
  • Prestige Consumer Healthcare Inc. reported Gross Profit of $634.46 million for fiscal year 2025.
  • Prestige Consumer Healthcare Inc. showed an increase of +1.6% in Gross Profit compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment